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CASE REPORT Open Access
Post-mortem histology in transient receptor
potential cation channel subfamily V
member 6 (TRPV6) under-mineralising
skeletal dysplasia suggests postnatal
skeletal recovery: a case report
Anna E. Mason1 , David Grier2, Sarah F. Smithson1,3, Christine P. Burren1,4 and Elise Gradhand5,6*
Abstract
Background: The calcium-selective channel TRPV6 (transient receptor potential cation channel subfamily V
member 6) is crucial for maternal-fetal calcium transport across the placenta. TRPV6 mutations have recently been
associated with an antenatally severe under-mineralising skeletal dysplasia accompanied by postnatal biochemical
abnormalities. This is the first post-mortem report in a patient with TRPV6 skeletal dysplasia.
Case presentation: The female infant had severe antenatal and postnatal skeletal abnormalities by 20 weeks gestation
and was ventilator-dependent from birth. These skeletal abnormalities were apparent at an earlier gestational age than in
previous reported cases and a more severe clinical course ensued. Biochemical and skeletal abnormalities, including bone
density, improved postnatally but cardiac arrest at 4 months of age led to withdrawal of intensive care. Compound
heterozygous TRPV6 variants (c.1978G > C p.(Gly660Arg) and c.1528C > T p.(Arg510Ter)) were identified on exome
sequencing. Post-mortem identified skeletal abnormalities but no specific abnormalities in other organ systems. No
placental pathology was found, multi-organ histological features reflected prolonged intensive care only. Post-mortem
macroscopic examination indicated reduced thoracic size and short, pale and pliable ribs. Histological examination
identified reduced number of trabeculae in the diaphyses (away from the growth plates), whereas metaphyses showed
adequate mineralisation and normal number of trabeculae, but with slightly enlarged reactive chondrocytes, indicating
post-natal skeletal growth recovery. Post-mortem radiological findings demonstrated improved bone density, improved
rib width, healed fractures, although ribs were still shorter than normal. Long bones (especially humerus and femur) had
improved from initial poorly defined metaphyses and reduced bone density to sharply defined metaphyses, prominent
growth restart lines in distal diaphyses and bone-in-bone appearance along diaphyses.
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Conclusions: This case provide bone histological confirmation that human skeletal development is compromised in the
presence of TRPV6 pathogenic variants. Post-mortem findings were consistent with abnormal in utero skeletal
mineralisation due to severe calcium deficit from compromised placental calcium transfer, followed by subsequent
phenotypic improvement with adequate postnatal calcium availability. Significant skeletal recovery occurs in the early
weeks of postnatal life in TRPV6 skeletal dysplasia.
Keywords: TRPV6 (transient receptor potential cation channel subfamily V member 6), Skeletal dysplasia, Placental
calcium transfer, Post-mortem
Background
Calcium is essential for cell signalling, neuromuscular ac-
tivity, blood coagulation and skeletal growth. During fetal
development, additional calcium is required to support
skeletal formation and development. This demand is met
by active maternal-foetal (transplacental) calcium trans-
port, to achieve higher fetal than maternal serum calcium
concentration [1]. Various mechanisms have been pro-
posed, with recent recognition of the importance of transi-
ent receptor potential cation channel subfamily V
member 6 (TRPV6; also referred to as vanilloid), an epi-
thelial calcium-selective channel formed of four identical
subunits, each with six transmembrane segments [2].
TRPV6 gene location and expression varies across species.
In humans, the TRPV6 gene is located on chromosome
7q33-q34 and is very highly expressed in the placenta [3].
Alteration in TRPV6 expression contributes to many
pathological processes, but only recently has a human
phenotype been identified. TRPV6 is upregulated in sev-
eral human malignancies, including prostate, thyroid,
breast and endometrial cancer, where it aids the calcium-
dependent proliferation of malignant cells [4–6]. Con-
versely, it is downregulated in pre-eclampsia, a condition
associated with reduced placental calcium transfer [7]. A
contributory potential role for TRPV6 has also been pos-
tulated in several rare childhood disorders including Lowe,
Pendred, Gitelman and Gordon syndromes; although
those disorders involve additional electrolyte abnormal-
ities, not present in this case, suggesting multiple mecha-
nisms within those disorders [8–11]. Prior to 2018,
TRPV6 had not been identified in human skeletal disease.
Very recently in 2018, homozygous or compound het-
erozygous TRPV6 variants have been reported in seven
infants with a skeletal disorder of antenatal-onset char-
acterised by poor mineralisation [12, 13]. All seven in-
fants had biochemical abnormalities of secondary
neonatal hyperparathyroidism which completely normal-
ised over several weeks. The skeletal abnormalities im-
proved to varying extents over a longer timeframe
during infancy. Our patient [12] showed more severe
skeletal abnormalities than the other six cases, and much
earlier in pregnancy. The variants in our case were dif-
ferent and the greater clinical severity is interpreted to
have been the consequence of the different location of
the pathogenic variants in this case compared to the
other 6 causing more severe impact on TRPV6 protein
function. Ultimately, this infant did not survive, due to
the initial postnatal respiratory impairment, ineffective
respiratory weaning and therefore complications of pro-
longed intensive care treatment. The detailed genetic
findings on this infant were published in the American
Journal of Medical Genetics 2018 and we refer the
reader back to that publication for detail on in silico
modelling and rationale of pathogenicity according to
ACMG Guidelines. Whereas, in this publication, we
focus on the post-mortem findings of this case, which
are the first in TRPV6-associated skeletal dysplasia,
shedding new insight into the abnormal bone architec-
ture of this condition and skeletal development in the
perinatal period.
Case presentation
A British White female infant had severe, potentially le-
thal, skeletal dysplasia detected antenatally at 20 weeks’
gestation. This consisted of short long bones, a small
chest, and rib deformities suggesting pulmonary hypo-
plasia. Antenatal microarray comparative genomic hy-
bridisation (CGH) and uniparental disomy (UPD)
testing, to exclude paternal UPD14, did not identify ab-
normalities. She was born at term (39 + 1/40) with nor-
mal birth weight (3128 g) and was ventilator-dependent
from birth due to respiratory distress. Physical examin-
ation showed a bell-shaped chest, but she was otherwise
well-grown and had no dysmorphic features or abnormal
neurology.
Skeletal survey showed persistent generalised under-
mineralisation, multiple rib and metaphyseal fractures
and periosteal reaction along long bone diaphyses
(Fig. 1). This was associated with significantly elevated
parathyroid hormone (PTH) during the first 6 weeks
(peak 101 pmol/L, reference range 1.1–6.9 pmol/L) but
normal corrected calcium, phosphate and alkaline phos-
phatase (ALP). Postnatal genetic testing, using targeted
single gene approach, excluded potential differential
diagnoses of Neonatal Severe Hyperparathyroidism,
Mucolipidosis Type II (I-cell disease), which can also
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feature hyperparathyroidism and periosteal changes, and
336 known skeletal dysplasias. Further details can be
found in the initial case report publication [12].
Whole exome sequencing was performed with DNA
samples from the patient and her unaffected parents
using the Agilent SureSelect All Exon v6 system, with
sequencing on an Illumina NextSeq 500. These afore-
mentioned negative genetic test finding reports coin-
cided with identifying resolution of PTH elevation and
progressively improving skeletal mineralisation. Conse-
quently, we considered an alternative hypothesis of an in
utero calcium deficiency caused by an intrinsic defect in
placental calcium transfer. This prompted direct explor-
ation of the candidate genes TRPV6, CABP9K and VDR.
We performed a gene-agnostic trio analysis to identify
very rare variants (Minor Allele Frequency < 0.0001)
compatible with autosomal recessive or de novo inherit-
ance. The likely causative variants were confirmed by
Sanger sequencing. 12 This analysis identified com-
pound heterozygous TRPV6 variants: novel maternally
inherited missense variant, c.1978G > C p.(Gly660Arg),
and paternally inherited nonsense variant, c.1528C > T
p.(Arg510Ter); both classified as pathogenic according
to ACMG Guidelines.
By 6 weeks of age, bone mineralisation showed radio-
logical improvement, but ventilatory requirement per-
sisted and was provided via tracheostomy from 8 weeks
of age. At 17 weeks, she developed rapid onset marked
abdominal distension, followed by two cardiac arrests as-
sociated with prolonged lactic acidosis. Prior to this, the
cardiac monitoring had shown no evidence of cardiac
malfunction or arrhythmias. Emergency laparotomy con-
firmed the presence of volvulus and dusky, but not is-
chaemic, bowel. Multi-organ failure, including global
ischaemic brain injury, was present and ultimately care
was withdrawn.
Fig. 1 Radiological findings. Upper panel (a-d) shows early postnatal plain radiographs (Day 12) and lower panel (e-h) shows corresponding post-
mortem plain radiographs. Bone density is considerably less in each upper panel image compared with lower images (skull a and e, chest b and
f, upper limb c and g, lower limb d and h). Chest X-rays (b and f): thoracic size is extremely reduced (b), to a lesser degree post-mortem (f),
which also shows broad and more calcified ribs, although with irregularities posteriorly and laterally consistent with healed fractures. Upper limb:
early postnatal imaging (c) shows ill-defined metaphyses; then (g) more sharply defined metaphyses, prominent growth restart lines in diaphyses
and bone-in-bone appearance. Lower limb: d shows initial poorly defined metaphyses, reduced bone density and metaphyseal fractures; then H
shows healed fractures, better metaphyseal delineation, prominent growth restart lines in diaphyses and bone-in-bone appearance
Mason et al. BMC Medical Genetics           (2020) 21:64 Page 3 of 7
Post-mortem skeletal survey radiographs were under-
taken (Fig. 1). They demonstrated considerably im-
proved bone density compared to early postnatal
imaging, metaphyseal regions had been ill-defined on
early postnatal imaging, but were far more sharply de-
fined, prominent growth restart lines were present in
long bone diaphyses and ossification was in keeping with
chronological age. The ribs remained extremely short,
were irregular posteriorly and laterally suggesting healed
fractures, and the thoracic volume was markedly
reduced.
A limited post-mortem autopsy was performed (chest,
abdomen, ribs and long bones only). The infant was
well-grown: body weight 6370 g, crown-heel length 62
cm, crown-rump length 45 cm and head circumference
43 cm (all within normal range for 4 months of age) with
no dysmorphic features, no abnormalities of skin or hair.
A narrow chest was noted.
There was evidence of abnormal rib and femur bone
architecture on macroscopic and microscopic examin-
ation. The bones were pale, unusually pliable and easily
cut away from the costo-cartilaginous junction with a
scalpel. Microscopically, the rib and femur metaphyses
showed growth plates with the expected three zones
(proliferative, hypertrophic and calcified cartilage), but
the chondrocytes were relatively enlarged and activated
in keeping with increased chondroid matrix production.
Towards the diaphyses, the trabeculae were of normal
structure but significantly reduced in number (Fig. 2).
The bone marrow was mildly autolysed but showed nor-
mal cellularity and a normal trilineage haematopoiesis.
Borderline lung hypoplasia was present (lung to body
weight ratio 0.017, abnormal < 0.015). Pulmonary micro-
scopic findings were in keeping with multi-organ failure,
with abundant alveolar macrophages, parenchymal and
intra-alveolar haemorrhage. No histological features of
infantile respiratory distress syndrome were seen. On
macroscopic examination, the heart was mildly enlarged
(weight 30.9 g, expected 23 g for crown-rump length),
but structurally normal with no pericardial effusion.
Microscopic examination showed mild hypertrophy and
disarray of the cardiomyocytes with a normal conduction
system. No significant areas of myocardial infarction
were noted.
Abdominal examination showed normal macroscopic
and microscopic appearance of the intestines with no
full thickness necrosis of the bowel or evidence of mal-
rotation. The caecum was mobile and there was a large
haemorrhage in the mesentery of the sigmoid colon with
approximately 20 ml of free blood in the abdominal cav-
ity in keeping with surgical intervention during emer-
gency laparotomy. The liver showed patchy hepatocyte
necrosis and prominent bilirubinostasis. The pancreas
appeared macroscopically normal and showed no
significant histological abnormality of endocrine and
exocrine glands. Immunohistochemical studies were not
possible due to the extent of autolysis.
Multisystem histological features consistent with in-
tensive care treatment where present but the exact aeti-
ology leading to cardiac arrest and subsequent multi-
organ failure could not be established.
There was no significant placental abnormality
(trimmed weight 400 g, 10-25th percentile for gestation),
including no focal changes on macroscopic or micro-
scopic examination on routine staining. There was no
evidence of viral infection. Immunohistochemical stain-
ing for TRPV6 was attempted using three antibodies
(AB20C6(C-term), AB429(C-term) and AB1271(N-
term)) on formalin-fixed, paraffin-embedded placental
tissue. Unfortunately, reliable staining could not be
achieved. The antibodies were developed for use on
fresh frozen tissue and it appears likely that the placental
TRPV6 antigen did not survive formalin fixation, al-
though this has not been formally tested.
In summary, post-mortem pathological examination
identified ongoing skeletal abnormality with pale, pliable
and short ribs. Post-mortem radiology illustrated consid-
erable improvement in bone density and metaphyseal
growth, supported by histological evidence of growth re-
covery with reactive chondrocytes and adequate minera-
lised normal trabeculae in the metaphyses, yet trabeculae
were sparse but normally structured in the diaphyses.
Discussion and conclusions
We report the findings at post-mortem of an infant with
antenatal-onset skeletal dysplasia caused by compound
heterozygous TRPV6 variants. TRPV6, a calcium-
selective channel, plays an important role in maternal-
foetal calcium transport via the placenta. Variants in
TRPV6 may lead to insufficient calcium transport and
abnormal skeletal development in utero. This leads to
postnatal skeletal and biochemical abnormalities which
progressively improve in the ex utero environment, as
described in seven recent cases.12,13 Skeletal findings im-
proved postnatally in all cases, although in our case [12]
the phenotype was extremely severe. In particular, the
abnormally small rib cage led to life-threatening respira-
tory insufficiency. Her ventilator-dependency had been
forecast to continue until approximately 18 months of
age (her unexpected death aged 4 months meant this
duration was ultimately not known). A further difference
in this case, is that the skeletal dysplasia was evident
much earlier antenatally, whereas in the Suzuki cases
skeletal abnormalities were only evident from the third
trimester onwards (earliest 28 weeks). Although
maternal-foetal calcium transfer begins at 12 weeks ges-
tation, the majority occurs during the third trimester so
it had been hypothesised that foetal bone abnormalities
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would not be evident earlier [14]. We suspect that the
significant skeletal dysplasia evident by only 20 weeks’
gestation in this case reflects the severity of the com-
promise to calcium transfer resulting from severely im-
paired TRPV6 function. In support of this, the variants
in TRPV6 identified in our patient were predicted, by in
silico protein modelling, to result in unstable or mis-
folded protein which might lead to channel loss or im-
paired activity.
The post-mortem findings further support the concept
of significant under-mineralisation due to lack of cal-
cium, especially the paleness, soft texture and flexibility
of the bones. Microscopically, the reduced bony trabecu-
lae persisting in the diaphyses may reflect earlier absent
or reduced calcium availability in utero, whereas the
reactive chondrocytes in the growth plate suggest bone
recovery and catch up in the normal calcium environ-
ment after birth. Significant bone remodelling occurs
during growth, so the reduction in trabecular number
might progressively normalise during childhood. Opti-
mism arises from other recent cases suggesting normal
postnatal growth, although duration is currently short
with minimal linear growth details. Yet recent Trpv6
mouse model studies by Fecher-Trost give caution as
cortical bone architecture remained abnormal in thick-
ness with reduced femoral length [15].
We consider it likely that the small lung volume was a
consequence of the skeletal dysplasia rather than due to
a primary pulmonary hypoplasia. This is supported by
the short ribs and markedly reduced thoracic volume.
Fig. 2 Histological Findings. a Histology of the femur at 2x magnification using Haematoxylin and Eosin (H + E) staining. This shows activated and
slightly irregular columns of chondrocytes, adequately mineralised trabeculae in the metaphyseal region of the endochondral ossification zone,
but reduced number of trabeculae in the diaphysis (see arrows). b Histology of the rib at 2x magnification using H + E staining showing
reduction in bony trabeculae of the rib
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Moreover, the lungs showed a normal pattern of lobar
development and furthermore there was no histological
remodelling of the lung tissue due to the inflammatory
changes typically seen in infantile respiratory distress
syndrome and, despite evidence of multi-organ failure,
there were no other significant pulmonary findings.
All organs were exposed to reduced calcium levels
during development, which could conceivably disrupt
physiological processes other than skeletal development.
The cardiac histology was examined in detail, as calcium
is essential for the conduction system and contractility
of the cardiomyocytes. The post-mortem findings of a
normal conduction system, along with the absence of
identified arrhythmias during her first 4 months of life,
provide no indication of a primary cardiac abnormality.
The mild cardiac hypertrophy and disarray of the cardio-
myocytes are non-specific findings and are post-mortem
findings not uncommonly seen in post-resuscitation,
consistent with recurrent adrenaline and/or corticoster-
oid administration. This correlates with the intensive
care treatment provided in this case rather than a result
of an abnormal calcium metabolism. Cardiac arrythmias
were not mentioned in the other cases. Our histological
findings do not raise abnormalities suggesting the need
for cardiac surveillance in surviving infants and children.
Clinically, there was no evidence of wider disorders of
calcium homeostasis. There was no pre-eclampsia and
no maternal factors that could account for in utero cal-
cium deficiency. Postnatally, oral calcium supplementa-
tion at physiological doses was given briefly to
compensate for an expected persistent hypocalcaemia
due to the skeletal calcium deficiency. However, normo-
calcaemia was maintained by a normal milk diet only,
indicating normal intestinal calcium absorption in the
postnatal period. The exocrine pancreas is another key
site for TRPV6 expression in humans, although signifi-
cance of its role is unclear. Unfortunately, histology in
this case was non-contributory due to autolysis. But an-
temortem, there had been no clinical evidence of pan-
creatic exocrine gland dysfunction, suggesting its role
may be minimal.
As more roles for TRPV6 in human disease are identi-
fied, further studies are vital to improve our understand-
ing of TRPV6 function and identify potential pathways
to prevent, modify or treat these disorders. Its upregula-
tion in many malignancies already makes it a promising
target for cancer therapy. Several groups have now de-
veloped systemic Trpv6 knock-out mice. The phenotypes
are variable between different mouse lines but include
male hypofertility, elevated PTH, growth retardation,
poor bone mineralisation and dermatitis [16–18]. How-
ever, clinical correlation to human disease is not straight
forward as organ-specific expression of TRPV6 varies
between species. Studying the foetal development of
Trpv6 knock-out mice will be extremely important in
advancing our understanding of antenatal calcium
homeostasis and identifying potential therapeutic inter-
vention in disorders such as pre-eclampsia and TRPV6
under-mineralising skeletal dysplasia. While intra-
amniotic calcium infusions could theoretically prevent
or correct bone abnormalities, improving thoracic
growth and optimising future lung function, their risk
profile of pregnancy loss means they are not a realistic
approach. It has been proposed that small molecular
chaperones, such as those used in cystic fibrosis, could
be used antenatally to correct the conformation of
TRPV6 variants, although this remains hypothetical at
present [13].
In summary, we report the first post-mortem histo-
logical and radiological findings of a patient with
TRPV6-associated skeletal dysplasia. The histology sug-
gests that metaphyses had been compromised due to se-
vere lack of calcium substrate, but then functioned
normally, in fact possibly more active, in the postnatal
environment. Bone development through collagen for-
mation is intrinsically abnormal in the majority of skel-
etal dysplasias. TRPV6-associated skeletal dysplasia
differs where the main feature appears to be compro-
mised development of bone quantity resulting from ex-
treme calcium lack during crucial in utero development.
The post-mortem radiology and histology in our case
suggested postnatal catch-up and recovery. Although, an
effect might persist as the trabeculae remained reduced
in number in the diaphyses. Whether bone remodelling
throughout longer childhood growth can completely
normalise bone length and density is currently unknown
and will require close monitoring in other cases.
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